These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 27542674)
21. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling. Hu BS; Xiong SM; Li G; Li JP Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549 [TBL] [Abstract][Full Text] [Related]
24. miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3. Cao T; Li H; Hu Y; Ma D; Cai X Tumour Biol; 2014 Nov; 35(11):10759-64. PubMed ID: 25073510 [TBL] [Abstract][Full Text] [Related]
25. miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7. Ma Y; She XG; Ming YZ; Wan QQ Tumour Biol; 2014 Nov; 35(11):10731-6. PubMed ID: 25073511 [TBL] [Abstract][Full Text] [Related]
26. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma. Zhang S; Li J; Wang X Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614 [TBL] [Abstract][Full Text] [Related]
27. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma. Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Lin J; Huang S; Wu S; Ding J; Zhao Y; Liang L; Tian Q; Zha R; Zhan R; He X Carcinogenesis; 2011 Nov; 32(11):1641-7. PubMed ID: 21890460 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
31. MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma. Liu H; Li W; Chen C; Pei Y; Long X Tumour Biol; 2015 Aug; 36(8):6313-9. PubMed ID: 25804796 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1. Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling. Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358 [TBL] [Abstract][Full Text] [Related]
36. Effects of hsa_circRBM23 on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 Expression. Wang B; Chen H; Zhang C; Yang T; Zhao Q; Yan Y; Zhang Y; Xu F Cancer Biother Radiopharm; 2018 Jun; 33(5):194-202. PubMed ID: 29916745 [TBL] [Abstract][Full Text] [Related]
37. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway. Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers. Hung CS; Liu HH; Liu JJ; Yeh CT; Chang TC; Wu CH; Ho YS; Wei PL; Chang YJ Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S360-8. PubMed ID: 22868917 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121 [TBL] [Abstract][Full Text] [Related]
40. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B. Yang F; Lv LZ; Cai QC; Jiang Y World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]